Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
4,594 results
- ASCLEPIOS IIndependent statistical analysis of Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ASDIndependent statistical analysis of Development of a Resiliency Training Program for Parents of Children With Autism Spectrum Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ASIA MRI ICDIndependent statistical analysis of A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ASPIREIndependent statistical analysis of Coaching Veterans to Healthy Weights and Wellness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00967668).
- ASPIREIndependent statistical analysis of Family-Focused, Stress-Reduction Program to Improve the Health Care of Urban Children With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ASPIRINIndependent statistical analysis of Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02409680).
- Aspirin for Treatment of Multiple Sclerosis-Related Fatigue: Complete Statistical AnalysisIndependent statistical analysis of Aspirin for Treatment of Multiple Sclerosis-Related Fatigue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00467584).
- Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation: Complete Statistical AnalysisIndependent statistical analysis of Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ASSENTIndependent statistical analysis of Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.: Complete Statistical AnalysisIndependent statistical analysis of Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo: Complete Statistical AnalysisIndependent statistical analysis of Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Assessing and Improving Patient Knowledge About Keloid Scars (Keloids): Complete Statistical AnalysisIndependent statistical analysis of Assessing and Improving Patient Knowledge About Keloid Scars (Keloids): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01176877).
- Assessing Neuroinflammation in GWI Using MRS: Complete Statistical AnalysisIndependent statistical analysis of Assessing Neuroinflammation in GWI Using MRS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04638998).
- Assessing PA-824 for Tuberculosis (the APT Trial): Complete Statistical AnalysisIndependent statistical analysis of Assessing PA-824 for Tuberculosis (the APT Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02256696).
- Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Assessing the Effect of a Blood-based Colorectal Cancer Screening Test on Screening Adherence and Colonoscopy Completion: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Effect of a Blood-based Colorectal Cancer Screening Test on Screening Adherence and Colonoscopy Completion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size…
- Assessment of a New “Boosting” Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Assessment of a New "Boosting" Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Assessment of Dystussia in Traumatic Brain Injury: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Dystussia in Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02240329).
- Assessment of KAN-101 in Celiac Disease (ACeD): Complete Statistical AnalysisIndependent statistical analysis of Assessment of KAN-101 in Celiac Disease (ACeD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04248855).
- Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO): Complete Statistical AnalysisIndependent statistical analysis of Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Assessment of the Effect of PAP on Energy and Vitality in Mild OSA Patients: The Merge Study: Complete Statistical AnalysisIndependent statistical analysis of Assessment of the Effect of PAP on Energy and Vitality in Mild OSA Patients: The Merge Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE): Complete Statistical AnalysisIndependent statistical analysis of Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Assessment of the Safety and the Performance of the SAGITTA EVL R Stems in Hip Arthroplasties: Complete Statistical AnalysisIndependent statistical analysis of Assessment of the Safety and the Performance of the SAGITTA EVL R Stems in Hip Arthroplasties: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ASSISTIndependent statistical analysis of AsseSSing Impact in pSoriatic Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05171270).
- ASSIST-RTIndependent statistical analysis of GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas: Complete Statistical AnalysisIndependent statistical analysis of Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ASSUREIndependent statistical analysis of A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01102972).
- ASSUREIndependent statistical analysis of Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03371485).
- ASTCIndependent statistical analysis of Antibacterial-coated Sutures at Time of Cesarean: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03386240).
- AstellasIndependent statistical analysis of A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AsthmaCareIndependent statistical analysis of Randomized Prospective Trial of a Mobile Health Application for Asthma Self-Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ASTRAL-5Independent statistical analysis of Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection: primary endpoint results,…
- Atacicept in Subjects With Optic Neuritis: Complete Statistical AnalysisIndependent statistical analysis of Atacicept in Subjects With Optic Neuritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00624468).
- ATALANTE-1Independent statistical analysis of OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- AtazanavirIndependent statistical analysis of Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site: Complete Statistical AnalysisIndependent statistical analysis of Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site: primary endpoint results, effect estimate with…
- Atezolizumab Immunotherapy in Patients With Advanced NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Atezolizumab Immunotherapy in Patients With Advanced NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03102242).
- ATLASIndependent statistical analysis of Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ATLASIndependent statistical analysis of Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ATNIndependent statistical analysis of Acute Renal Failure Trial Network (ATN) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00076219).